Nicox SA Ownership

NICXFDelisted Stock  USD 0.44  0.00  0.00%   
Nicox SA maintains a total of 50.16 Million outstanding shares. Nicox SA secures 6.32 % of its outstanding shares held by insiders and 17.02 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Nicox SA in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nicox SA, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Nicox Pink Sheet Ownership Analysis

About 17.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nicox SA has Price/Earnings (P/E) ratio of 146.39. The entity recorded a loss per share of 1.23. The firm had not issued any dividends in recent years. Nicox SA had 1:5 split on the 3rd of December 2015. Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.The quote for Nicox SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nicox SA contact Michele Garufi at 33 4 97 24 53 00 or learn more at https://www.nicox.com.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Nicox Pink Sheet

If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like